ARCHIVES

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

This article is from The Cancer Letter archive.

Vol. 23 No. 36 | September 19, 1997

Download PDF Visit The Full Archive

Related Articles

Budget Year

November 12, 2010

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

April 29, 2011

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

Lung Cancer Incidence Decreases Significantly In White Males For First Time In At Least 30 Years

December 6, 1985

NCI to Spend 40 Percent of Stimulus Funds On Contracts

June 26, 2009